Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages

Veterinary Immunology and Immunopathology

Volumn 66, Issue 1, 1998, Pages 1-10

  Hawkins, D L ^a   MacKay, R J ^a   MacKay, S L D ^b   Moldawer, L L ^b  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Equine peritoneal macrophages; IL 10; IL 6; LPS; Nitric oxide; PGE2; TNF

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; NITRIC OXIDE; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORSE; INFLAMMATION; MEDIATOR RELEASE; MONOLAYER CULTURE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; CELLS, CULTURED; DINOPROSTONE; HORSES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; NITRIC OXIDE; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032491370     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00181-0     Document Type: Article

References (39)

1. Alder H., Frech B., Thony M., Pfister H., Peterhans E., Jungi T.W. Inducible nitric oxide synthase in cattle: differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J. Immunol. 154:1995;4710-4718.
2. Arias M., Zabaleta J., Rodriguez J.L., Rojas M., Paris S.C., Garcia L.F. Failure to induce nitric oxide production by human monocyte-derived macrophages. Manipulation of biochemical pathways. Allergol Immunopathol (Madr). 25:1997;280-288.
3. Barton M.H., Collatos C., Moore J.N. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet. J. 28:1996;382-389.
4. Bertone A.L., Palmer J.L., Jones J. Synovial fluid inflammatory mediators as markers of equine synovitis (Abstr.). Veterinary Surgery. 22:1993;372-373.
5. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267:1992;23301-23308.
6. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1991;1549-1555.
7. Cargile, J.L., MacKay, R.J., Dankert, J.R., Skelley, B.S., 1995a. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of Miniature Horses given endotoxin. Am. J. Vet. Res. 56, 1451-1459.
8. Cargile, J.L., MacKay, R.J., Dankert, J.R., Skelley, B.S., 1995b. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in Miniature Horses given endotoxin. Am. J. Vet. Res. 56 1445-1450.
9. Cerami A., Beutler B. The role of cachectin/TNF in endotoxic shock and cachexia. Immunol. Today. 9:1988;28-31.
10. Chomarat P., Banchereau J., Miossec P. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum. 38:1995;1046-1054.
11. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
12. Dumarey C.H., Labrousse V., Rastogi N., Vargaftig B.B., Bachelet M. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukoc Biol. 56:1994;3640.
13. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics. 20:1964;482-491.
14. Fiedler V.B., Loof I., Sander E., Voehringer V., Galanos C., Fournel M.A. Monoclonal antibody to tumor necrosis factor-α prevents lethal endotoxin sepsis in adult rhesus monkeys. J. Lab. Clin. Med. 120:1992;574-588.
15. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
16. Fong Y., Lowry S.F. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 55:1990;157-170.
17. Geng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sc. 91:1994;8602-8606.
18. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
19. Glausner M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732.
20. Johnson P.J., Moore L.A., Cogswell A.M., Allen G.K. Activation of equine pulmonary alveolar macrophages does not yield nitric oxide. (Abstract #16). J. Vet. Int. Med. 11:1997;107.
21. G-methyl-l-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1990;1132-1138.
22. Kruisbeek, A., 1991. In vitro assays for mouse B and T-cell function. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology, Vol. 1, John Wiley & Sons, New York. pp. 3.1.3-3.1.5.
23. Levin J., Tomasulo J.P.A., Oser R.S. Detection of endotoxin in human blood and demonstration of an inhibitor. J. Lab. Clin. Med. 75:1970;903-905.
24. MacKay, R.J., King, R.R., Dankert, J.R., Reis, K.J., Skelley, L.A., 1991a. Cytotoxic tumor necrosis factor activity produced by equine alveolar macrophages: preliminary characterization. Vet. Immunol. Immunopathol. 29, 15-30.
25. MacKay R.J., Lester G.D. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. Am. J. Vet. Res. 53:1992;1285-1289.
26. MacKay, R.J., Merritt, A.M., Zertuche, J.-M., Whittington, M., Skelley, L.A., 1991b. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am. J. Vet. Res. 52, 533-538.
27. Mathison J.C., Wolfson E., Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1988;1925-1937.
28. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J. Biol. Chem. 269:1994;21322-21329.
29. Morris D.D., Crowe N., Moore J.N., Moldawer L.L. Endotoxin-induced production of interleukin 6 by equine peritoneal macrophages in vitro. Am. J. Vet. Res. 53:1992;1298-1301.
30. Morris D.D., Moore J.N. Endotoxin-induced production of thromboxane and prostacyclin by equine peritoneal macrophages. Circ. Shock. 23:1987;295-303.
31. Morris D.D., Moore J.N., Fischer K., Tarleton R. Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages. Circ. Shock. 30:1990;229-236.
32. Niiro H., Otsuka T., Tanabe T., Hara S., Kuga S., Nemoto Y., Tanaka Y., Nakashima H., Kitajima S., Abe M., Niho Y. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood. 85:1995;3736-3745.
33. Padgett E.L., Pruett S.B. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 186:1992;775-781.
34. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol. 115:1995;684-688.
35. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. 82:1985;7738-7742.
36. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1985;662-664.
37. van der Pouw Kraan T., Boeije L.C.M., Smeenk R.J.T., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interkeukin 12 production. J. Exp. Med. 181:1995;775-779.
38. Wang C.L., Su M.H., Chao T.Y., Shaio M.F., Yang K.D. When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions. Proc. Natl. Sci. Counc. Republ. China B. 20:1996;65-70.
39. Wang P., Siegel M.I., Egan R.W., Billah M.M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:1994;811.